Featuring: Hishda Mohamed, Senior Marketing Lead, Croda Beauty Active

Summary

Hishda Mohamed discusses Croda Beauty Active’s launch of Matrixyl® Neolide™ at in-cosmetics Global 2026. The encapsulated peptide technology is designed to support smarter peptide release, enhanced bioavailability and growing consumer demand for longevity-focused skin care.

Introducing Matrixyl® Neolide™

At this year’s in-cosmetics Global, Croda Beauty Active is showcasing Matrixyl® Neolide™an encapsulated peptide innovation based on the original Matrixyl® — the iconic collagen peptide first brought to the beauty industry 25 years ago.

The technology uses a solid lipid particle with a peptide at its core, allowing for smarter release into the skin and improved bioavailability.

Pull quote: “This allows a smarter peptide release into the skin, enhancing bioavailability.”

Responding to Longevity and Efficacy Demands

Mohamed says the launch is especially relevant now because it addresses two major industry priorities: longevity and efficacy.

For Croda Beauty Active, the aim is to make peptide technology more accessible and relevant to consumers globally.

What Customers Are Asking For

At the show, Mohamed says customers are increasingly interested in how they can support longevity claims while also delivering greater performance and more reliable technology.

This reflects a wider shift in skin care, where brands are looking for ingredients that can combine scientific credibility with visible, consumer-relevant results.

Key Takeaways for Brands

• Peptides remain central to longevity-focused skin care innovation.
• Encapsulation technologies are helping improve ingredient delivery.
• Bioavailability is becoming a key performance marker for active ingredients.
• Brands are seeking reliable technologies that support both efficacy and consumer trust.